Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.

Study identified numerous influential “hub genes” that offer promising new targets for early detection and therapeutic intervention.

More than 120 peer-reviewed cell types have already been successfully cryopreserved using Bambanker ™, all consolidated in one place for easy access and reference. Background. C ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research. A type of aggressive, treatment-resistant brain ...

Whether it’s counting red blood cells under a light microscope or recording bursts of electricity as neurons fire, scientists spend a lot of time studying cells. With such a diversity in form and ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

Researchers discover how much inner-ear damage it takes to affect balance, showing why small declines can trigger major symptoms.

Sana's first-in-human study shows HIP technology allows islet cells to avoid immune rejection and produce insulin without immunosuppression. Reliance on initial results: The press release heavily ...